Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.99 is 55% below its 3-year average of 11.05, near the low end of its 3-year range (0.00–32.19).
As of the fiscal period ended Tuesday, June 30, 2026. 41.99% below its 12-month average of 8.61.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.99.
CURRENT RATIO
4.99
CURRENT RATIO AVG TTM
8.61
CURRENT RATIO AVG 3Y
11.05
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-41.99%
CURRENT VS 3Y AVG
-54.79%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+33.19%
vs the sector median at left
Market Cap
$1.60B
Current Ratio
13.11
TTM Avg
13.03
3Y Avg
9.21
5Y Avg
8.89
Market Cap
$1.62B
Current Ratio
2.91
TTM Avg
2.71
3Y Avg
3.12
5Y Avg
3.05
Market Cap
$1.59B
Current Ratio
4.69
TTM Avg
5.56
3Y Avg
3.02
5Y Avg
3.21
Market Cap
$1.56B
Current Ratio
7.69
TTM Avg
5.54
3Y Avg
6.46
5Y Avg
10.83
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Septerna Inc (SEPN) | $1.61B | 4.99 | 8.61 | 11.05 | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.60B | 13.11 | 13.03 | 9.21 | 8.89 |
| uniQure N.V. (QURE)vs › | $1.61B | 10.01 | 10.09 | 8.82 | 10.31 |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 1.64 | 1.40 | 1.84 | 1.88 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 2.91 | 2.71 | 3.12 | 3.05 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | 1.89 | 2.40 | 2.37 | 2.65 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | 4.69 | 5.56 | 3.02 | 3.21 |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.56B | 7.69 | 5.54 | 6.46 | 10.83 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 16.01 | 8.50 | 7.33 | 23.22 |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.53B | 6.77 | 5.11 | 9.27 | 12.43 |
Current Ratio
4.99
Quick Ratio
4.99
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.99 |
| 2026-03-31 | 4.71 |
| 2025-12-31 | 4.73 |
| 2025-09-30 | 6.53 |
| 2025-06-30 | 22.09 |
| 2025-03-31 | 32.19 |
| 2024-12-31 | 27.77 |
| 2024-09-30 | 10.08 |
| 2024-06-30 | 19.48 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.00 |
| 2023-09-30 | 0.00 |
